Colossal Biosciences announced more funding at a $1.5 billion valuation.
Max Knoblauch is a Daily Writer for Morning Brew, specializing in creating headlines and graphics. With a focus on a wide range of topics, Max covers everything from biotech startups to sports retirements, tech mishaps to cultural trends. Max's work is engaging, informative, and brings a unique perspective to the Morning Brew audience.